Celltrion Pharm Inc (068760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Celltrion Pharm Inc (068760) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩23.44 Billion ≈ $15.89 Million USD) by net assets (₩426.42 Billion ≈ $288.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 068760 market cap for the company's overall valuation and market capitalisation.

Celltrion Pharm Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Celltrion Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Celltrion Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celltrion Pharm Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Celltrion Pharm Inc to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shinva Medical Instrument Co Ltd SHG:600587	-0.003x
Imperial Metals Corporation TO:III	0.051x
Aryzta AG SW:ARYN	0.302x
Financial Street Holdings Co Ltd SHE:000402	0.018x
Willis Lease Finance Corporation NASDAQ:WLFC	0.100x
Kolon Industries Inc KO:120110	0.024x
TRUSTPILOT GROUP LS -01 F:6VZ	N/A
ABOUT YOU Holding AG F:YOU	-0.403x

Annual Cash Flow Conversion Efficiency for Celltrion Pharm Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Celltrion Pharm Inc from 2014 to 2024. View 068760 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩396.92 Billion ≈ $268.99 Million	₩56.59 Billion ≈ $38.35 Million	0.143x	+513.25%
2023-12-31	₩376.67 Billion ≈ $255.26 Million	₩8.76 Billion ≈ $5.93 Million	0.023x	+305.01%
2022-12-31	₩356.79 Billion ≈ $241.79 Million	₩-4.05 Billion ≈ $-2.74 Million	-0.011x	-104.04%
2021-12-31	₩331.97 Billion ≈ $224.97 Million	₩93.15 Billion ≈ $63.13 Million	0.281x	+132.68%
2020-12-31	₩300.56 Billion ≈ $203.69 Million	₩36.25 Billion ≈ $24.56 Million	0.121x	+21.24%
2019-12-31	₩280.03 Billion ≈ $189.77 Million	₩27.85 Billion ≈ $18.88 Million	0.099x	+87.67%
2018-12-31	₩270.03 Billion ≈ $183.00 Million	₩14.31 Billion ≈ $9.70 Million	0.053x	+253.13%
2017-12-31	₩293.62 Billion ≈ $198.98 Million	₩-10.16 Billion ≈ $-6.89 Million	-0.035x	+21.58%
2016-12-31	₩344.65 Billion ≈ $233.56 Million	₩-15.21 Billion ≈ $-10.31 Million	-0.044x	-178.02%
2015-12-31	₩236.23 Billion ≈ $160.09 Million	₩13.36 Billion ≈ $9.06 Million	0.057x	-29.99%
2014-12-31	₩214.43 Billion ≈ $145.31 Million	₩17.33 Billion ≈ $11.74 Million	0.081x	--

About Celltrion Pharm Inc

KQ:068760 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

₩1.70 Trillion KRW

Market Cap Rank

#8306 Global

#218 in Korea

Share Price

₩39050.00

Change (1 day)

+0.64%

52-Week Range

₩38000.00 - ₩75700.00

All Time High

₩222138.48